"Drug Carriers" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Forms to which substances are incorporated to improve the delivery and the effectiveness of drugs. Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, decrease drug metabolism, and reduce drug toxicity. Carriers are also used in designs to increase the effectiveness of drug delivery to the target sites of pharmacological actions. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, and carrier erythrocytes among others have been employed as biodegradable drug carriers.
| Descriptor ID |
D004337
|
| MeSH Number(s) |
D26.255.260 E02.319.300.380
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Drug Carriers".
Below are MeSH descriptors whose meaning is more specific than "Drug Carriers".
This graph shows the total number of publications written about "Drug Carriers" by people in this website by year, and whether "Drug Carriers" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 2 | 2 |
| 2001 | 0 | 1 | 1 |
| 2002 | 1 | 1 | 2 |
| 2003 | 0 | 1 | 1 |
| 2004 | 0 | 1 | 1 |
| 2005 | 2 | 1 | 3 |
| 2006 | 2 | 1 | 3 |
| 2007 | 1 | 1 | 2 |
| 2008 | 3 | 5 | 8 |
| 2009 | 2 | 1 | 3 |
| 2010 | 5 | 3 | 8 |
| 2011 | 7 | 2 | 9 |
| 2012 | 3 | 3 | 6 |
| 2013 | 7 | 5 | 12 |
| 2014 | 3 | 5 | 8 |
| 2015 | 6 | 1 | 7 |
| 2016 | 9 | 5 | 14 |
| 2017 | 6 | 2 | 8 |
| 2018 | 5 | 1 | 6 |
| 2019 | 1 | 1 | 2 |
| 2020 | 3 | 7 | 10 |
| 2021 | 0 | 3 | 3 |
| 2022 | 0 | 4 | 4 |
| 2023 | 0 | 3 | 3 |
| 2024 | 2 | 2 | 4 |
| 2025 | 3 | 3 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Drug Carriers" by people in Profiles.
-
Aare M, Padakanti SC, Singh M. In Vivo Pharmacodynamic and Pharmacokinetic Assessment of Cannabidiol-loaded Camel Milk Exosomes in Doxorubicin-resistant Triple-negative Breast Cancer Xenografts. AAPS PharmSciTech. 2025 Sep 11; 26(7):227.
-
Marathe S, Joshi R, Yang R, Shadambikar G, Bachmann AS, Chougule MB. Integration of Design of Experiments for the Development and Evaluation of Sulfasalazine Loaded Hybrid Albumin Chitosan Based Polymeric Nanocarriers. AAPS PharmSciTech. 2025 Jul 14; 26(6):192.
-
Patel N, Desai A, Vyas B, Shah P, Shubhada M, Milind U, Pathak K, Chougule MB. Integration of Synchronizing?In Silico,?In Vitro, and?In Vivo?Strategies for the Development of Antipsoriatic Apremilast-loaded Nanostructured Lipid Carrier Embedded in Hydrogel. AAPS PharmSciTech. 2025 Apr 25; 26(5):115.
-
Srivastav AK, Jaiswal J, Rajput PK, Yadav UCS, Singh R, Kumar U. In silico and in vitro profiling of sphingomyelin loaded zein nanoconstructs with optimized aromatic interactions and pharmacokinetics for colon cancer therapeutics. Int J Biol Macromol. 2025 May; 307(Pt 1):141845.
-
Pan WY, Weng PW, Wu SH, Hsiao CH, Jheng PR, Nguyen HN, Tseng CL, Burnouf T, Rethi L, Nguyen HT, Huang WY, Wang TJ, Chuang AE. Intranasal delivery of epigallocatechin gallate-laden platelet extracellular vesicles for mitigating retinal glaucoma. J Control Release. 2025 May 10; 381:113596.
-
Mandala B, Berko Y, Battogtokh G, Fisusi F, Gao H, Akala EO. Nanotechnology Platform for the Delivery of Docetaxel and Tyrosine Kinase Inhibitors for HER2-Positive Breast Cancer Therapy. Pharm Nanotechnol. 2025; 13(5):1017-1043.
-
Chuang AE, Chen YL, Chiu HJ, Nguyen HT, Liu CH. Nasal administration of polysaccharides-based nanocarrier combining hemoglobin and diferuloylmethane for managing diabetic kidney disease. Int J Biol Macromol. 2024 Dec; 282(Pt 1):136534.
-
Gangavarapu A, Tapia-Lopez LV, Sarkar B, Pena-Zacarias J, Badruddoza AZM, Nurunnabi M. Lipid nanoparticles for enhancing oral bioavailability. Nanoscale. 2024 Oct 10; 16(39):18319-18338.
-
Ngo AN, Chatman KK, Douglas D, Mosley-Kellum KM, Wu K, Vadgama J. Engineering of layer-by-layer acetate-coated paclitaxel loaded poly(lactide-co-glycolide) acid nanoparticles for prostate cancer therapy- in vitro. J Pharm Sci. 2024 Nov; 113(11):3375-3383.
-
Wang TJ, Rethi L, Ku MY, Nguyen HT, Chuang AE. A review on revolutionizing ophthalmic therapy: Unveiling the potential of chitosan, hyaluronic acid, cellulose, cyclodextrin, and poloxamer in eye disease treatments. Int J Biol Macromol. 2024 Jul; 273(Pt 2):132700.